» Articles » PMID: 7316975

Effects of Aliphatic Fatty Acids on the Binding of Phenol Red to Human Serum Albumin

Overview
Journal Biochem J
Specialty Biochemistry
Date 1981 Jun 1
PMID 7316975
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Binding of Phenol Red to human serum albumin at pH 7.0 was studied by ultrafiltration (n1 = 1, K1 = 3.9 X 1-(4) M-1, n2 = 5, K2 = 9.6 X 10(2) M-1). The presence of 1 mol of octanoate or decanoate per mol of albumin caused a decrease in dye binding (dye/protein molar ratio 1:1), which, in contrast with additional fatty acid, was very pronounced: 1-8 mol of palmitate or stearate resulted in a small, and apparently linear, displacement of Phenol Red. The displacement effect of 1-5 mol of oleate, linoleate or linolenate per mol of albumin was comparable with that of the equimolar concentrations of palmitate or stearate. A higher molar ratios the unsaturated acids caused a drastic decrease in dye binding. The different Phenol Red-displacement effects of low molar ratios of medium-chain and long-chain fatty acids indicate that these acids have different high-affinity binding sites. In accordance with this proposal, low concentrations of stearate had only a small effect on the Phenol Red-displacement effect of octanoate. Phenol Red-binding curves in the presence of 1 mol of octanoate, 8 mol of stearate and 6 or 7 mol of linolenate per mol of albumin respectively indicated that the dye and the fatty acids do not complete for a common primary binding site. In contrast, a secondary Phenol Red-binding site could be identical with the primary octanoate-binding site. Furthermore, the primary Phenol Red-binding site could be the same as a secondary linolenate-binding site. Assignment of the different primary binding sites for Phenol Red and for medium-chain and long-chain fatty acids to a model of the secondary structure of albumin is attempted.

Citing Articles

Insight into the Interaction Mechanism of HSA with Aztreonam: A Multispectroscopic and Computational Approach.

Sabour A, Khan A, Alhuzani M Molecules. 2022; 27(22).

PMID: 36431957 PMC: 9698515. DOI: 10.3390/molecules27227858.


Interaction of palmitic Acid with metoprolol succinate at the binding sites of bovine serum albumin.

Rahman M, Prianka F, Shohel M, Mazid M Adv Pharm Bull. 2014; 4(4):379-83.

PMID: 25436195 PMC: 4137429. DOI: 10.5681/apb.2014.056.


The investigation of the binding of 6-mercaptopurine to site I on human serum albumin.

Sochacka J, Baran W Protein J. 2012; 31(8):689-702.

PMID: 23001616 PMC: 3483484. DOI: 10.1007/s10930-012-9449-y.


Recombinant Human Albumin in Cell Culture: Evaluation of Growth-Promoting Potential for NRK and SCC-9 Cells In Vitro.

Keenan J, Dooley M, Pearson D, Clynes M Cytotechnology. 2012; 24(3):243-52.

PMID: 22358768 PMC: 3449618. DOI: 10.1023/A:1007916930200.


In-vitro relationship between protein-binding and free drug concentrations of a water-soluble selective beta-adrenoreceptor antagonist (atenolol) and its interaction with arsenic.

Alam M, Awal M, Subhan N, Mostofa M J Health Popul Nutr. 2009; 27(1):20-30.

PMID: 19248645 PMC: 2761805. DOI: 10.3329/jhpn.v27i1.3315.


References
1.
WATSON D . Albumin and "total globulin" fractions of blood. Adv Clin Chem. 1965; 8:237-303. View

2.
DOLE V . A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956; 35(2):150-4. PMC: 438791. DOI: 10.1172/JCI103259. View

3.
King T, Spencer M . Structural studies and organic ligand-binding properties of bovine plasma albumin. J Biol Chem. 1970; 245(22):6134-48. View

4.
Weber G . Ligand binding and internal equilibria in proteins. Biochemistry. 1972; 11(5):864-78. DOI: 10.1021/bi00755a028. View

5.
Ashbrook J, Spectro A, Fletcher J . Medium chain fatty acid binding to human plasma albumin. J Biol Chem. 1972; 247(21):7038-42. View